Innovación, terapia y desarrollo farmacéutico en oftalmología
INNOFTAL
![Foto de Innovación, terapia y desarrollo farmacéutico en oftalmología](/img/grupo.png)
![Foto de Hospital Universitario de Valladolid](/img/noimage_org.png)
Hospital Universitario de Valladolid
Valladolid, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario de Valladolid (6)
2023
-
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients
Seminars in Arthritis and Rheumatism, Vol. 58
2021
-
Dexamethasone plga microspheres for sub-tenon administration: Influence of sterilization and tolerance studies
Pharmaceutics, Vol. 13, Núm. 2, pp. 1-21
2020
-
Spectrum of Headaches Associated With SARS-CoV-2 Infection: Study of Healthcare Professionals
Headache, Vol. 60, Núm. 8, pp. 1697-1704
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
2018
-
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451
2015
-
Association between SNPs of metalloproteinases and prostaglandin f2α receptor genes and latanoprost response in open-angle glaucoma
Ophthalmology, Vol. 122, Núm. 5, pp. 1040-1048.e4